Navigation Links
Bradmer announces management changes
Date:10/3/2007

Based on this experience, Dr. Ahmad has a strong working knowledge of cGMP and CMC documentation for IND and BLA preparation. From an academic perspective, Dr. Ahmad held the position of Senior Scientist/Assistant Professor at Indiana University, and was a Visiting Fellow at the National Institutes of Health in Bethesda, MD. He received his Ph.D in Biochemistry from Aligarh University in India. He has published numerous peer reviewed articles including nine papers in the Journal of Biological Chemistry.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. To date, over US$60 million in grants and related support has driven research and development of the licensed treatment, which has been delivered to over 200 patients with promising results and has completed Phase II clinical trials at Duke University. Bradmer is currently in the process of organizing a prospective multi-center clinical trial of the licensed treatment. Neuradiab has been granted Orphan Drug Status by both the U.S. Food and Drug Administration and the European Medicines Agency.

Bradmer Pharmaceuticals Inc.'s common shares have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of Rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws.

Except for historical information, this press
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... York (PRWEB) September 02, 2014 - ... defined as a class of diagnostic test that analyzes ... The nucleic acids and proteins that belong to individual ... therapy, health condition, or risk of developing a specific ... better known as (MDx) evaluating the new class of ...
(Date:9/2/2014)... 02, 2014 Welcome to Arthritis ... 4.6 million Canadians living with the disease, The Arthritis ... Arthritis” video series featuring well-known Canadians from different walks ... ,      Lloyd Robertson , veteran news anchor ... skier ,      Amy Cotton , two-time ...
(Date:9/2/2014)... there might be a new salve to dominate medicine cabinets ... lowly salamander. Salamanders may not be the cuddliest of animals, ... of seriously damaged body parts. Now, a new report published ... Journal , identifies a small protein (called a "peptide") ... to unlocking the secret of this amazing wound healing trick ...
(Date:9/2/2014)... Two Kansas State University biochemists have discovered a family ... Staphylococcus aureus , a pathogenic bacterium that can ... , Brian Geisbrecht, professor of biochemistry and molecular biophysics, ... S. aureus , which is the cause of increasing ... journal Proceedings of the National Academy of Sciences ...
(Date:9/2/2014)... New York (PRWEB) September 02, 2014 ... the bony block or the vertebrae in our spine ... are the most common fractures in people with osteoporosis ... major reason behind such fractures, forms of metastatic tumors ... fall or a sports injury can also lead to ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 2Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 3Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 4Health News:‘Voices of Arthritis’ Launches Awareness Month 2Health News:‘Voices of Arthritis’ Launches Awareness Month 3Health News:Salamander skin peptide promotes quick and effective wound healing in mice 2Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:An Overview of the Minimally Invasive Vertebral Compression Fracture Repair Market by Transparency Market Research 2Health News:An Overview of the Minimally Invasive Vertebral Compression Fracture Repair Market by Transparency Market Research 3
... Investigacin Oncolgica (GENYO) of which the University of Granada, ... identified the genetic and phenotypic changes that cause tumor ... the main cause of cancer death- is caused by ... relationship with the organ originally affected. For this to ...
... the University of Michigan Health System shows the risk ... following the implementation of Model of End Stage Liver ... how liver transplant allocation is decided. The study, ... in the Department of Internal Medicine, examined the effect ...
... developing disorders like addiction and depression, according to a ... Proceedings of the National Academy of Sciences . ... coauthor of the paper and a professor of neuroscience ... Sciences. She and coauthor David Sturman, a MD/PhD student ...
... Calif. Researchers at the Stanford University School of Medicine ... effectively predict how deadly a cancer will be. The discovery, ... faster, less expensive and more accurate analysis of cancer risk ... published online Jan. 16 in the Proceedings of the ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... to help most patients suffering from chronic obstructive pulmonary disease ... Emphysema and chronic bronchitis are the two main forms of ... hard for people to breathe. Since most COPD patients ...
... Mozes HealthDay Reporter , MONDAY, Jan. 16 (HealthDay ... significantly more likely to develop acne than their normal-weight peers, ... weight, and more specifically body mass index (BMI, a ratio ... of the common skin condition among teens. Teens, responses ...
Cached Medicine News:Health News:University of Granada researchers identify changes in tumor cells that lead to metastasis 2Health News:U-M News: Kidney failure risk higher for liver transplant patients following policy change 2Health News:Adolescents' brains respond differently than adults' when anticipating rewards 2Health News:Stanford computer algorithm used to identify bladder cancer marker 2Health News:Stanford computer algorithm used to identify bladder cancer marker 3Health News:Vitamin D Won't Help Most COPD Patients: Study 2Health News:Vitamin D Won't Help Most COPD Patients: Study 3Health News:Overweight Teen Girls May Have Higher Acne Risk 2Health News:Overweight Teen Girls May Have Higher Acne Risk 3
(Date:9/2/2014)... Mast Therapeutics, Inc . (NYSE MKT: MSTX) today announced that the ... at the Rodman and Renshaw 16 th Annual Global Investment ... in the Holmes II Salon at The New York Palace Hotel ... parties can access a live audio webcast and slide presentation on ... presentation will be available on the web site for 30 days. ...
(Date:9/2/2014)... SEATTLE , Sept. 2, 2014 /PRNewswire/ ... company committed to the development and commercialization ... today announced that the U.S. Food and ... designation to the investigation of motolimod (VTX-2337) ... doxorubicin (PLD) for the treatment of women ...
(Date:9/2/2014)... , September 2, 2014 , ... EMITF ) announced today following the Company,s ... Ltd. ("Elbit Medical") (TASE: EMTC-M), a subsidiary of the ... fully diluted basis, announced that on September 1, 2014 ... 30.8% of the voting power ("Gamida Cell") and vast ...
Breaking Medicine Technology:Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 2VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 3Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3
... 2011 Eli Lilly and Company (NYSE: LLY ) ... on Monday, April 18, 2011.  Lilly will also conduct a conference ... further detail the company,s financial performance. The conference ...  Investors, media and the general public can access a live webcast ...
... 6, 2011 Pure Biomed LLC has launched a ... facial treatments for quick, temporary relief of nerve pain ... of nerve damage.  Reunion is the only full line ... Reunion products were developed from the ground ...
Cached Medicine Technology:Affordable Nerve Pain Treatment Now Available in the U.S. 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: